Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | — | — |
Developed full body maculopapular morbilloform rash 5 days after vaccine given. no fever, URI symptoms. no change in activity and she was well-appearing. she also had pharyngeal erythema.
treated for left AOM 12/8 with amoxicillin- medication completed prior to vaccine administration.
Atrial septal defect; history of SVT now resolved
none
none
Negative strep PCR testing done on 1/5/2026